5 Key Takeaways

• 1

  A smartphone-based fecal immunochemical test (FIT) demonstrated diagnostic performance comparable to laboratory-based FITs for colorectal cancer screening.

• 2

  The study enrolled 654 patients, with 55% using the smartphone-based FIT and 98% using the laboratory FIT, highlighting differences in participation.

• 3

  The smartphone-based FIT achieved a sensitivity of 28% for detecting advanced neoplasms, compared to 34% for the laboratory FIT, with identical specificity at 92%.

• 4

  Positive feedback was noted, with 92% of participants agreeing the app provided clear guidance and 89% finding the test duration appropriate.

• 5

  Barriers to smartphone-based FIT usage included technical issues and skepticism, with 47% citing compatibility problems and 44% expressing doubts about digital testing.